Cargando…
Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation
Ischemic stroke risk in atrial fibrillation differs from patient to patient, depending on numerous variables. Many attempts have been made to translate this difference into simple numbers and to compare it to the hemorrhagic risk of anticoagulation. Different clinical scores have been studied to def...
Autores principales: | Pezzo, Mario Piergiulio, Tufano, Antonella, Franchini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877602/ https://www.ncbi.nlm.nih.gov/pubmed/35207188 http://dx.doi.org/10.3390/jcm11040915 |
Ejemplares similares
-
Atrial Fibrillation, Cancer and Echocardiography
por: Galderisi, Maurizio, et al.
Publicado: (2020) -
Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
por: Matos, Jason D., et al.
Publicado: (2018) -
Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022) -
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020) -
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
por: Rago, Anna, et al.
Publicado: (2023)